Buy Iovance Biotherapeutics Stock | LBIO Stock Price & Latest News | Public
LBIO

Iovance Biotherapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About LBIO

    Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utiliz...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.18
    -0.37
    -0.55
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.46

    Actual EPS
    Q3 2020

    Stats

    Market Cap$4,64B
    Volume35,43k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$41.49
    1 Year Low$17.67
    Open$32.77
    High$32.80
    Low$31.35

    Buy any stock with any amount of money.

    Download the App
    Download the app